CTC Seminar:

Monitoring the effectiveness of cancer treatment

Dr. Katherina Pachmann, together with Dr. Joachim Fluhrer

Sign on below.

You'll meet world-renowned CTC scientist Prof. Katherina Pachmann, learn how you can use CTC-tests to determine treatment success and meet Oncologists, Medical Doctors and other Healthcare Practitioners who are using the Maintrac testing to personalise cancer treatment programs. A nutritious meal will be provided.

The Seminar

Circulating Tumour Cells (CTCs) are the metastasising population of cancer cells. CTCs are now well established as independent prognostic indicators of metastatic disease. CTC enumeration and analysis represents a 'fluid-biopsy,' with results now firmly associated with clinical outcome. Practitioners and Oncologists who are interested or are already benefiting from using CTC-tests will be in attendance.

Prof. Katherina Pachmann is a world-renowned expert in Circulating Tumour Cell science - both in research and in translational medicine. She has worked internationally in academically and scientifically acclaimed cell research centers. She will be presenting new research at COSA and the World Cancer Congress in November in Melbourne, as well as presenting seminars to practitioners in locations around Australia and New Zealand.

Dr. Joachim Fluhrer has recently been acknowledged internationally for Excellence in Integrative Medicine, and will be touring alongside Prof. Pachmann. Dr. Fluhrer brings his clinical and medical expertise to the discussion table, and is passionate about facilitating the best in evidence-based medical research for use in the clinical setting.

This seminar will be a unique opportunity to meet CTC expert scientist Prof. Pachmann and discuss clinical cases you might have with her and Dr. Fluhrer together. The seminar will include updates on the latest in CTC-technology and how it is revolutionising cancer monitoring, and will be a great chance to meet and discuss personalised cancer treatment with colleagues.

What you can expect

Meet the expert CTC scientist who has been working with scientists and practitioners across the globe to develop now very well clinically-validated method of CTC-testing, and become up-to-date with the latest in CTC science and utility.

Learn how you can use CTCs to potentiate cancer treatment monitoring in your clinic. This includes a discussion on the practical selection of available tests, report analysis and case-studies brought by both presenters and attendees.

Discover the ins and outs of why the cost-effective Maintrac® test is becoming the gold standard of CTC-testing in Europe and is now being accepted and supported by mainstream oncologists for monitoring treatment effectiveness in real-time
The network of Oncologists and practitioners who are applying CTC-testing to assist in cancer management is rapidly expanding. The use of CTCs in cancer monitoring and personalised treatment design is allowing better patient outcomes.

These seminars offer practitioners a unique opportunity to meet and discuss personalised cancer management with scientific and clinical experts, become up-to-date in the latest scientific developments in the field and to meet with practitioners successfully utilising CTC testing in their clinic.

Seminar dates:


Monday 1st December 2014
6:00pm - 9:00pm
Worral Lecture Theatre, Sydney Eye Hospital
Maquarie st Sydney.

Gold Coast:

Wednesday 3rd December 2014
6:00pm - 9:00pm
Ground Floor, 328 Scottsdale Drive, Robina Qld 4226


Thursday 4th December 2014
6:00pm - 9:00pm
National Institute of Integrative Medicine
Top floor, 21 Burwood Rd, Hawthorn VIC


Sunday 7th December 2014
12:00pm - 3:00pm
Novotel Hotel, Ray Emery Drive
Auckland International Airport

Sign-on here:

Name *
Please select which seminar you would like to attend
Please let us know of any food allergies / intolerances as there will be a nutritious meal provided
I am a certified health practitioner currently registered in Australia or New Zealand *
This is to ensure the event is attended by practitioners only

Genostics Tests




BT logo CMYK 500x430px 72dpi with byline.jpg
ACMN logo RGB 500x470px 72 dpi.jpg